Investigation and verification of GIMAP6 as a robust biomarker for prognosis and tumor immunity in lung adenocarcinoma.

Chen, Xiuqiong; Li, Zhaona; Wang, Xinyue; Zhou, Jing; Wei, Qianhui; Chen, Kaidi; Jiang, Richeng

Chen, Xiuqiong; Li, Zhaona; Wang, Xinyue; Zhou, Jing; Wei, Qianhui; Chen, Kaidi; Jiang, Richeng.

Afiliação

Chen X; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Li Z; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Wang X; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Zhou J; Department of Thoracic Oncology, Tianjin Lung Cancer Center, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin, 300060, People's Republic of China.
Wei Q; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Chen K; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Jiang R; Tianjin's Clinical Research Center for Cancer, Tianjin, China.

J Cancer Res Clin Oncol ; 149(13): 11041-11055, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37338641

Assuntos

Adenocarcinoma de Pulmão; Neoplasias Pulmonares; Humanos; GTP Fosfo-Hidrolases; Prognóstico; Biomarcadores; Adenocarcinoma de Pulmão/genética; Neoplasias Pulmonares/genética; Microambiente Tumoral/genética

Palavras-chave

GTPase of immunity-associated protein 6; Immunity; Immunotherapy; Lung adenocarcinoma; Prognosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google